Drawing on the perspectives of Presidents of leading European nuclear medicine societies, this publication reflects on how the field has evolved over the past five years and how it may develop over the next decade. It examines recent technological and therapeutic advances, explores projections toward 2035, and identifies the clinical areas where nuclear medicine is expected to deliver the greatest impact.
Together, these contributions offer a structured and experience-based view of nuclear medicine at a time of rapid transformation, from the expansion of radioligand therapy and advanced imaging systems to the growing integration of data-driven and multidisciplinary approaches in clinical care.